Helen Bennis, Senior Director at Ipsos, chats with Dr Stephanie Anne Baker, whose research focuses on how rumours, false, and misleading information travels online with a particular focus on health and wellness, and, Dr Camilla Stokholm, GP and author of ‘What your doctor eats’.

In the first of two parts they discuss:

• The profound benefit accurate and well-intentioned online health information can have on peoples’ lives, using Dr Camilla Stockholm’s personal experience as an ‘accidental influencer’
• The reasons why we have seen a proliferation of online mis / dis information in recent years
• The strategies employed to gain trust online and how this has changed over time

Obesity care in the US is in the midst of a true transformation — one that’s redefining science, access, and the patient experience.

In the latest episode of Obesity: The Big Picture Podcast, Jackie Ilacqua, President of Syndicated Healthcare Research at Ipsos, is joined by two of the leading voices in obesity and metabolic research — Dr. Donna Ryan and Professor David Allison — to explore how innovation, access, and trust are redefining what effective obesity care looks like today.

From breakthrough therapies and expanding Medicare coverage to the emerging understanding of “food noise” and the challenge of public trust, this episode unpacks the forces driving this new era of care.

But as access to GLP-1 therapies grows, important questions remain: Who’s being left out, and why? How do we ensure that innovation doesn’t widen existing gaps in care and equity?

Tune in to 'Spotlight on the US Obesity Care Revolution' to hear how science, policy, and people are converging to shape the next chapter of obesity treatment in America.

Real world evidence is changing the healthcare landscape, but what does it mean in practicality for chronic diseases like obesity?

In this episode of Obesity: The Big Picture podcast, host Ramota Alaran, Associate Director of Real-World Evidence at Ipsos, sits down with independent consultant Madhu Kubra (formerly Global Director at Otsuka and GSK) to unpack how real-world evidence (RWE) is transforming obesity research, care, and policy.

From integrated evidence planning to the utilisation of the patient voice in RWE studies, this episodes tackles the types of real world data that can be used to address the obesity crisis and what regulators need to be considering.

Want to learn more? Register today to join us at our RWE event, 30 October: https://www.ipsos.com/en-uk/amplifying-patient-voice-real-world-evidence